The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Posener, J. A.
* Articles by Schatzberg, A. F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Posener, J. A.
* Articles by Schatzberg, A. F.
Related Collections
* Neuroendocrinology
* Depression
Am J Psychiatry 158:2083-2085, December 2001
© 2001 American Psychiatric Association


Brief Report

Cortisol Feedback During the HPA Quiescent Period in Patients With Major Depression

Joel A. Posener, M.D., Charles DeBattista, D.M.H., M.D., Gordon H. Williams, M.D., and Alan F. Schatzberg, M.D.

OBJECTIVE: The authors tested the hypothesis that patients with major depression have a defect in the mechanism by which cortisol exerts negative feedback on the hypothalamic-pituitary-adrenal (HPA) axis during the HPA axis quiescent period. METHOD: Twenty-nine patients with major depression and 25 healthy comparison subjects were randomly assigned to administration of 15 mg cortisol or placebo infused over 2 hours beginning at 7:00 p.m. Cortisol and ACTH levels were measured at baseline and every 30 minutes from 7:30 p.m. to 11:00 p.m. RESULTS: Differences between the patients and the comparison subjects in the ACTH response to the cortisol infusion, relative to the ACTH response to placebo, were not found. CONCLUSIONS: The results provide some evidence that patients with major depression do not have an abnormality of cortisol feedback during the HPA axis quiescent period.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
H. Jahn, M. Schick, F. Kiefer, M. Kellner, A. Yassouridis, and K. Wiedemann
Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Arch Gen Psychiatry, December 1, 2004; 61(12): 1235 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
U. Voderholzer, F. Hohagen, T. Klein, J. Jungnickel, C. Kirschbaum, M. Berger, and D. Riemann
Impact of Sleep Deprivation and Subsequent Recovery Sleep on Cortisol in Unmedicated Depressed Patients
Am J Psychiatry, August 1, 2004; 161(8): 1404 - 1410.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org